Open AccessMesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses
Author(s) -
Qianqian Chen
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i29.4702
Subject(s) - foxp3 , mesenchymal stem cell , stem cell , rar related orphan receptor gamma , immunology , colitis , inflammatory bowel disease , medicine , bone marrow , cancer research , gata3 , biology , immune system , pathology , microbiology and biotechnology , transcription factor , disease , biochemistry , gene
To investigate the potential therapeutic effects of mesenchymal stem cells (MSCs) in inflammatory bowel disease (IBD), we transplanted MSCs into an experimental model of IBD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom